跳至主要内容
临床试验/JPRN-UMIN000007169
JPRN-UMIN000007169已完成未知

Pharmacokinetics test of pyridoxamine in uremic patients on peritoneal dialysis - Pharmacokinetics of pyridoxiamine

Tokai University School of Medicine0 个研究点目标入组 6 人开始时间: 2012年2月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Receiving hemodialysis in addition to peritoneal dialysis Severe liver disease or liver dysfunction History of allergy or adverse effects to certain drugs Participating in other clinical trials or received investigational products in the last 16 weeks Having active cancers or received complete resection of cancers in the last 3 years History of cardiovascular disease in the last 6 months Receiving peritoneal dialysis for more than 8 years or having suspected encapsulating peritoneal sclerosis Fontaine stage II peripheral arterial disease Treatment resistant hypertension Treatment resistant diabetes Erythropoietin resistant anemia Received aminophylline, theophylline, choline theophylline, or levodopa in the last 4 weeks Pregnant women or those intending to become pregnant during the next 1 year

研究者

相似试验